Nx. Zeng et al., Role of neuropeptide-sensitive L-type Ca2+ channels in histamine release in gastric enterochromaffin-like cells, AM J P-GAST, 277(6), 1999, pp. G1268-G1280
Citations number
63
Categorie Soggetti
da verificare
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Peptides release histamine from enterochromaffin-like (ECL) cells because o
f elevation of intracellular Ca2+ concentration ([Ca2+](i)) by either recep
tor-operated or voltage-dependent Ca2+ channels (VDCC). To determine whethe
r VDCCs contribute to histamine release stimulated by gastrin or pituitary
adenylate cyclase-activating polypeptide (PACAP), the presence of VDCCs and
their possible modulation by peptides was investigated in a 48-h cultured
rat gastric cell population containing 85% ECL cells. Video imaging of fura
a-loaded cells was used to measure [Ca2+](i), and histamine was assayed by
RIA. Cells were depolarized by increasing extracellular K+ concentrations
or by 20 mM tetraethylammonium (TEA(+)). Cell depolarization increased tran
sient and steady-state [Ca2+](i) and resulted in histamine release, depende
nt on extracellular Ca2+. These K+- or TEA(+)-dependent effects on histamin
e release from ECL cells were coupled to activation of parietal cells in in
tact rabbit gastric glands, and L-type channel blockade by 2 mu M nifedipin
e inhibited 50% of [Ca2+](i) elevation and histamine release. N-type channe
l blockade by 1 mu M omega-conotoxin GVIA inhibited 25% of [Ca-i(2+]) eleva
tion and 14% of histamine release. Inhibition was additive. The effects of
20 mM TEA(+) were fully inhibited by 2 mu M nifedipine. Both classes of Ca2
+ channels were found in ECL cells, but not in parietal cells, by RT-PCR. N
ifedipine reduced PACAP-induced (but not gastrin-stimulated) Ca2+ entry and
histamine release by 40%. Somatostatin, peptide YY (PYY), and galanin dose
dependently inhibited L-type Ca2+ channels via a pertussis toxin-sensitive
pathway. L-type VDCCs play a role in PACAP but not gastrin stimulation of
histamine release from ECL cells, and the channel opening is inhibited by s
omatostatin, PYY, and galanin by interaction with a G(i) or G(o) protein.